INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "SUBCUTANEOUS ADMINISTRATION OF ANTI-DLL3 AGENT FOR TREATMENT OF CANCER"

GENEVA, March 25 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/046254) for "SUBCUTANEOUS ADMINISTRATION OF ANTI-DLL3 AGENT FOR TREATMENT OF CANCER" on Sep 12, 2025. With publication no. WO/2026/060304, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MINOCHA, Mukul (c/o Amgen Inc.One Amgen Center DriveLaw Department - Patent Operations M/S 28-5-AThousand Oaks, CA 91320-1799), PARKES, Amanda (c/o Amgen Inc.One Amgen Center DriveLaw Department - Patent Operations M/...